Understanding structure-activity relationships of pH-sensitive cationic lipids facilitates the rational identification of promising lipid nanoparticles for delivering siRNAs in vivo.
Animals
Cations
/ chemistry
Drug Carriers
/ chemistry
HeLa Cells
Humans
Hydrogen-Ion Concentration
Lipids
/ chemistry
Liver
/ metabolism
Mice, Inbred BALB C
Mice, Inbred ICR
Nanoparticles
/ chemistry
RNA Interference
RNA, Small Interfering
/ administration & dosage
Spleen
/ metabolism
Structure-Activity Relationship
Delivery
Endosomal escape
Hepatocytes
Lipid nanoparticles
Structure-activity relationship
pH-sensitive cationic lipid
siRNA
Journal
Journal of controlled release : official journal of the Controlled Release Society
ISSN: 1873-4995
Titre abrégé: J Control Release
Pays: Netherlands
ID NLM: 8607908
Informations de publication
Date de publication:
10 02 2019
10 02 2019
Historique:
received:
11
09
2018
revised:
21
12
2018
accepted:
01
01
2019
pubmed:
6
1
2019
medline:
19
5
2020
entrez:
6
1
2019
Statut:
ppublish
Résumé
Lipid nanoparticles (LNPs) are one of the more promising technologies for efficiently delivering short interfering RNA (siRNA) in vivo. A pH-sensitive cationic lipid that facilitates the targeting of hepatocytes and endosomal escape, strongly influences the availability of siRNA, thus making it a key material for efficient siRNA delivery. A systematic knowledge regarding lipid structure-activity relationships would greatly facilitate the development of sophisticated pH-sensitive cationic lipids for use in siRNA-based therapeutics. The systemic derivatization of a hydrophilic head group and hydrophobic tails of YSK12-C4, a pH-sensitive cationic lipid that was developed in our laboratory, revealed that hydrophilic head significantly affected the apparent pKa of the final product, a key factor in both intrahepatic distribution and endosomal escape. The clogP value of a hydrophilic head group was found to be associated with the apparent pKa of the product. In contrast, the hydrophobic tail structure strongly affected intrahepatic distribution without depending on apparent pKa. A structure-activity relationship study enabled the selection of an adequate combination of a hydrophilic head group and hydrophobic tails and permitted a potent LNP composed of a pH-sensitive cationic lipid CL4H6 (CL4H6-LNPs) to be developed that showed efficient gene silencing activity (50% effective dose: 0.0025 mg/kg), biodegradability and was tolerated. In vivo experiments revealed that the CL4H6-LNPs showed a superior efficiency for endosomal escape, cytosolic release and the RNA-induced silencing for the complex-loading of siRNAs compared to the previously developed LNPs.
Identifiants
pubmed: 30610950
pii: S0168-3659(19)30001-X
doi: 10.1016/j.jconrel.2019.01.001
pii:
doi:
Substances chimiques
Cations
0
Drug Carriers
0
Lipids
0
RNA, Small Interfering
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
140-152Informations de copyright
Copyright © 2019 Elsevier B.V. All rights reserved.